Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 مناظر
administrator
07/14/23
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
مزید دکھائیں
فیس بک کے تبصرے
کوئی تبصرہ نہیں ملا